Azenta (AZTA) Income from Discontinued Operations (2012 - 2024)
Azenta (AZTA) posted quarterly Income from Discontinued Operations of 819000.0 for Q4 2024, up 49.13% year-over-year from 549183.67 in Q1 2024, and up 49.13% quarter-over-quarter from 1610000.0 in Q4 2023.
Azenta (AZTA) Income from Discontinued Operations (2012 - 2024) Analysis & Trends
Azenta (AZTA) has reported Income from Discontinued Operations for 8 consecutive years, with 819000.0 the latest figure, recorded in Q4 2024.
- In Q4 2024, Income from Discontinued Operations rose 49.13% year-over-year to 819000.0; the TTM figure through Dec 2024 stood at 15544000.0 (down 96.68% YoY), while the FY2022 annual figure was 480673000.0, up 1259.48% from the prior year.
- Income from Discontinued Operations advanced to 819000.0 in Q4 2024 per AZTA's latest filing, from 1610000.0 in the prior quarter.
- Across five years, Income from Discontinued Operations topped out at 451860000.0 in Q1 2022 and bottomed at 1610000.0 in Q4 2023.
- Historically, Income from Discontinued Operations has averaged 51360100.0 across 5 years, with a median of 9394500.0 in 2021.
- On a YoY basis, Income from Discontinued Operations climbed as much as 5120.8% in 2022 and fell as far as 89.29% in 2022.
- Azenta's Income from Discontinued Operations stood at 6012000.0 in 2020, then surged by 80.31% to 10840000.0 in 2021, then soared by 55.79% to 16888000.0 in 2022, then sank by 109.53% to 1610000.0 in 2023, then surged by 49.13% to 819000.0 in 2024.
- Business Quant data shows AZTA's Income from Discontinued Operations at 819000.0 in Q4 2024, 1610000.0 in Q4 2023, and 16888000.0 in Q3 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Discontinued) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | - |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | -74.00 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | - |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | - |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | - |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | - |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | - |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | -9.00 Mn |
| 10 | Azenta | 1.69 Bn | 1.37 Bn | 198.10 Mn | -10.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -819,000.00 |
| Dec 31, 2023 | -1.61 Mn |
| Sep 30, 2022 | 16.89 Mn |
| Jun 30, 2022 | 1.09 Mn |
| Mar 31, 2022 | 451.86 Mn |
| Dec 31, 2021 | 10.84 Mn |
| Sep 30, 2021 | 10.56 Mn |
| Jun 30, 2021 | 10.13 Mn |
| Mar 31, 2021 | 8.66 Mn |
| Dec 31, 2020 | 6.01 Mn |
| Mar 31, 2014 | 907,000.00 |
| Dec 31, 2013 | 907,000.00 |
| Sep 30, 2013 | -2.18 Mn |
| Mar 31, 2013 | -456,000.00 |
| Dec 31, 2012 | 216,000.00 |